GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2018-03-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10549-018-4751-9PMID 29574636PMCID PMC6110614
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions.

  2017cited by this paper
• Polymorphisms in genes related to epithelial–mesenchymal transition and risk of non-small cell lung cancer

  2017cited by this paper
• How Ligands Illuminate GPCR Molecular Pharmacology.

  2017cited by this paper
• Expression and prognostic role of orphan receptor GPR110 in glioma.

  2017cited by this paper
• Pristimerin inhibits proliferation, migration and invasion, and induces apoptosis in HCT-116 colorectal cancer cells.

  2016cited by this paper
• FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer

  2016cited by this paper
• Adhesion G protein-coupled receptors are activated by exposure of a cryptic tethered agonist

  2015cited by this paper
• Targeting thyroid hormone receptor beta in triple-negative breast cancer

  2015cited by this paper
• Basal Protein Expression Is Associated With Worse Outcome and Trastuzamab Resistance in HER2+ Invasive Breast Cancer.

  2015cited by this paper
• Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.

  2015cited by this paper
• The Concise Guide to PHARMACOLOGY 2015/16: G protein‐coupled receptors

  2015cited by this paper
• The CBM Complex Underwrites NF-κB Activation to Promote HER2-Associated Tumor Malignancy

  2015cited by this paper
• Resistance to Anti-HER2 Therapies in Breast Cancer.

  2015cited by this paper
• β-Adrenergic receptors suppress Rap1B prenylation and promote the metastatic phenotype in breast cancer cells

  2015cited by this paper
• Maintenance of the hematopoietic stem cell pool in bone marrow niches by EVI1-regulated GPR56

  2013cited by this paper
• Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.

  2013cited by this paper
• The Orphan Adhesion G Protein-coupled Receptor GPR97 Regulates Migration of Lymphatic Endothelial Cells via the Small GTPases RhoA and Cdc42*

  2013cited by this paper
• GPR116, an adhesion G-protein-coupled receptor, promotes breast cancer metastasis via the Gαq-p63RhoGEF-Rho GTPase pathway.

  2013cited by this paper
• Adhesion G Protein-Coupled Receptors: Signaling, Pharmacology, and Mechanisms of Activation

  2012cited by this paper
• Adhesion family of G protein-coupled receptors and cancer.

  2012cited by this paper
• Structural insights into agonist-induced activation of G-protein-coupled receptors.

  2011cited by this paper
• Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers -- role of estrogen receptor and HER2 reactivation

  2011cited by this paper
• LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells.

  2011cited by this paper
• Trends in the exploitation of novel drug targets

  2011cited by this paper
• β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib

  2011cited by this paper
• Effects of ovarian cancer G protein coupled receptor 1 on the proliferation, migration, and adhesion of human ovarian cancer cells.

  2011cited by this paper
• GPR56 Plays varying roles in endogenous cancer progression

  2010cited by this paper
• Orphan receptor GPR110, an oncogene overexpressed in lung and prostate cancer

  2010cited by this paper
• Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.

  2010cited by this paper
• Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion

  2008cited by this paper
• Mitogenic signaling pathways induced by G protein‐coupled receptors

  2007cited by this paper
• G-protein-coupled receptors and cancer

  2007cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy.

  2007cited by this paper
• A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

  2006cited by this paper
• Assessment of degradation and ubiquitination of CXCR4, a GPCR regulated by EGFR family members.

  2006cited by this paper
• EGF–ERBB signalling: towards the systems level

  2006cited by this paper
• The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.

  2003cited by this paper
• Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation.

  2002cited by this paper
• Novel human G protein‐coupled receptors with long N‐terminals containing GPS domains and Ser/Thr‐rich regions

  2002cited by this paper
• ErbB2 is essential in the prevention of dilated cardiomyopathy

  2002cited by this paper
• Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

  1989cited by this paper

• Nonclassical Cannabinoid Receptors: Modern Concepts of Signal Transmission Functions and Mechanisms

  2025cites this paper
• Interactions between ADGRF1 (GPR110) and extracellular matrix proteins govern its effects on tumorigenesis in HER2‐positive breast cancer

  2025influential citation
• Let-7b, miR-29b, and miR-125b as Potential Biomarkers for Differentiating Canine Mammary Carcinoma Histological Types

  2024cites this paper
• Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (Adgrf1)

  2023cites this paper
• Identifying a core protein signature of small extracellular vesicles derived from B‐cell precursor acute lymphoblastic leukaemia

  2023cites this paper
• NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer

  2022cites this paper
• Blocking Gi/o-Coupled Signaling Eradicates Cancer Stem Cells and Sensitizes Breast Tumors to HER2-Targeted Therapies to Inhibit Tumor Relapse

  2022influential citation
• A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets in Uterine Corpus Endometrial cancer.

  2022cites this paper
• Adhesion G Protein-Coupled Receptors: Structure, Signaling, Physiology and Pathophysiology.

  2022cites this paper
• GPR110 promotes progression and metastasis of triple-negative breast cancer

  2022cites this paper
• Screening of GPCR drugs for repurposing in breast cancer

  2022cites this paper
• Amelioration of non-alcoholic fatty liver disease by targeting G protein-coupled receptor 110: A preclinical study

  2022cites this paper
• A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients

  2021cites this paper
• A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2‐positive breast cancer

  2021cites this paper
• Opportunities and challenges for drug discovery in modulating Adhesion G protein-coupled receptor (GPCR) functions

  2020cites this paper
• The Emerging Role of Adhesion GPCRs in Cancer.

  2020cites this paper
• Structure, function and therapeutic potential of adhesion GPCRs

  2020cites this paper
• The role of GPR110 in lung cancer progression

  2020cites this paper
• Transmembrane Peptides as Inhibitors of Protein-Protein Interactions: An Efficient Strategy to Target Cancer Cells?

  2020cites this paper
• Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axis

  2019cites this paper
• Adhesion G protein-coupled receptors: opportunities for drug discovery

  2019cites this paper
• Bioinformatics Analysis of Stromal Molecular Signatures Associated with Breast and Prostate Cancer

  2019cites this paper
• GPCRomics: An Approach to Discover GPCR Drug Targets.

  2019cites this paper
• Clinicopathological and prognostic significance of aberrant G protein-couple receptor 110 (GPR110) expression in gastric cancer.

  2019cites this paper
• of radioresistance in glioblastoma stem-like

  year unknowncites this paper